HEADER TRANSFERASE 14-DEC-20 7B9L TITLE MEK1 IN COMPLEX WITH COMPOUND 23 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1, COMPND 3 DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: MKK1,ERK ACTIVATOR KINASE 1,MAPK/ERK KINASE 1,MEK 1,MKK1,ERK COMPND 6 ACTIVATOR KINASE 1,MAPK/ERK KINASE 1,MEK 1; COMPND 7 EC: 2.7.12.2,2.7.12.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP2K1, MEK1, PRKMK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, ALLOSTERIC, FRAGMENTS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.KACK,L.OSTER REVDAT 2 31-JAN-24 7B9L 1 REMARK REVDAT 1 03-MAR-21 7B9L 0 JRNL AUTH P.DI FRUSCIA,F.EDFELDT,I.SHAMOVSKY,G.W.COLLIE,A.AAGAARD, JRNL AUTH 2 L.BARLIND,U.BORJESSON,E.L.HANSSON,R.J.LEWIS,M.K.NILSSON, JRNL AUTH 3 L.OSTER,J.PEMBERTON,L.RIPA,R.I.STORER,H.KACK JRNL TITL FRAGMENT-BASED DISCOVERY OF NOVEL ALLOSTERIC MEK1 BINDERS. JRNL REF ACS MED.CHEM.LETT. V. 12 302 2021 JRNL REFN ISSN 1948-5875 JRNL PMID 33603979 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00563 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 74282 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 3664 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.71 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.89 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1486 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2312 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1418 REMARK 3 BIN R VALUE (WORKING SET) : 0.2301 REMARK 3 BIN FREE R VALUE : 0.2555 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.58 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 68 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4689 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 113 REMARK 3 SOLVENT ATOMS : 442 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.96020 REMARK 3 B22 (A**2) : -0.99430 REMARK 3 B33 (A**2) : 5.95450 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.220 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.109 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.100 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.103 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.097 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4956 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6689 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1805 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 863 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4956 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 1 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 624 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6140 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.41 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.41 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -25.2998 -8.8921 21.2225 REMARK 3 T TENSOR REMARK 3 T11: 0.0061 T22: -0.0608 REMARK 3 T33: -0.0689 T12: 0.0106 REMARK 3 T13: 0.0003 T23: -0.0146 REMARK 3 L TENSOR REMARK 3 L11: 1.0483 L22: 0.6699 REMARK 3 L33: 0.6988 L12: 0.3857 REMARK 3 L13: 0.1885 L23: 0.1727 REMARK 3 S TENSOR REMARK 3 S11: -0.0100 S12: 0.0108 S13: -0.0087 REMARK 3 S21: -0.0086 S22: 0.0122 S23: 0.0190 REMARK 3 S31: 0.0457 S32: 0.0848 S33: -0.0021 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -26.8513 4.5390 -13.5943 REMARK 3 T TENSOR REMARK 3 T11: -0.0617 T22: -0.0186 REMARK 3 T33: -0.0416 T12: 0.0095 REMARK 3 T13: 0.0075 T23: 0.0089 REMARK 3 L TENSOR REMARK 3 L11: 0.7301 L22: 0.6761 REMARK 3 L33: 1.5943 L12: 0.1076 REMARK 3 L13: -0.5264 L23: 0.0133 REMARK 3 S TENSOR REMARK 3 S11: 0.0541 S12: 0.1086 S13: 0.0774 REMARK 3 S21: -0.0213 S22: 0.0230 S23: 0.0834 REMARK 3 S31: -0.1342 S32: -0.2496 S33: -0.0771 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7B9L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1292112989. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.1-6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX IV REMARK 200 BEAMLINE : BIOMAX REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 473128 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 79.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3E8N REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE OBTAINED FROM HANGING REMARK 280 DROPS BY MIXING A 1:1 RATIO OF PROTEIN SOLUTION WITH WELL REMARK 280 SOLUTION CONTAINING 2 M AMSO4, 0.1 M NACL AND 0.1 M BIS-TRIS PH REMARK 280 6.1-6.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.97500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.08000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.04000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.08000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.97500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.04000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 20 REMARK 465 ALA A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 HIS A 24 REMARK 465 HIS A 25 REMARK 465 HIS A 26 REMARK 465 HIS A 27 REMARK 465 ALA A 28 REMARK 465 ALA A 29 REMARK 465 ALA A 30 REMARK 465 GLU A 31 REMARK 465 ASN A 32 REMARK 465 ALA A 220 REMARK 465 ASN A 221 REMARK 465 SER A 222 REMARK 465 PHE A 223 REMARK 465 VAL A 224 REMARK 465 GLY A 225 REMARK 465 THR A 226 REMARK 465 GLY A 302 REMARK 465 SER A 303 REMARK 465 GLY A 304 REMARK 465 SER A 305 REMARK 465 GLY A 306 REMARK 465 SER A 307 REMARK 465 GLN A 383 REMARK 465 MET B 20 REMARK 465 ALA B 21 REMARK 465 HIS B 22 REMARK 465 HIS B 23 REMARK 465 HIS B 24 REMARK 465 HIS B 25 REMARK 465 HIS B 26 REMARK 465 HIS B 27 REMARK 465 ALA B 28 REMARK 465 ALA B 29 REMARK 465 ALA B 30 REMARK 465 GLU B 31 REMARK 465 ASN B 32 REMARK 465 LEU B 33 REMARK 465 TYR B 34 REMARK 465 PHE B 35 REMARK 465 GLN B 36 REMARK 465 LEU B 37 REMARK 465 GLU B 38 REMARK 465 GLU B 39 REMARK 465 LEU B 40 REMARK 465 ASN B 221 REMARK 465 SER B 222 REMARK 465 PHE B 223 REMARK 465 VAL B 224 REMARK 465 GLY B 225 REMARK 465 THR B 226 REMARK 465 GLY B 306 REMARK 465 ASN B 382 REMARK 465 GLN B 383 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 41 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 42 106.19 49.75 REMARK 500 GLU A 102 78.97 -118.68 REMARK 500 ASP A 136 65.26 34.56 REMARK 500 ARG A 189 -7.52 79.15 REMARK 500 ASP A 190 47.21 -146.46 REMARK 500 ASP B 136 69.12 32.49 REMARK 500 ARG B 189 -8.28 80.29 REMARK 500 ASP B 190 47.67 -146.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 405 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 195 OD1 REMARK 620 2 ASP A 208 OD2 91.5 REMARK 620 3 ANP A 401 O2G 90.2 88.9 REMARK 620 4 ANP A 401 O2B 90.6 176.8 93.6 REMARK 620 5 ANP A 401 O1A 174.2 87.3 95.5 90.4 REMARK 620 6 HOH A 582 O 82.0 89.0 171.8 88.9 92.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 403 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 195 OD1 REMARK 620 2 ASP B 208 OD2 91.4 REMARK 620 3 ANP B 401 O2G 94.1 89.3 REMARK 620 4 ANP B 401 O2B 92.3 175.6 92.8 REMARK 620 5 ANP B 401 O1A 168.3 83.1 96.2 92.8 REMARK 620 6 HOH B 537 O 79.5 86.5 172.2 91.9 89.8 REMARK 620 N 1 2 3 4 5 DBREF 7B9L A 37 263 UNP Q02750 MP2K1_HUMAN 37 263 DBREF 7B9L A 308 383 UNP Q02750 MP2K1_HUMAN 308 383 DBREF 7B9L B 37 263 UNP Q02750 MP2K1_HUMAN 37 263 DBREF 7B9L B 308 383 UNP Q02750 MP2K1_HUMAN 308 383 SEQADV 7B9L MET A 20 UNP Q02750 INITIATING METHIONINE SEQADV 7B9L ALA A 21 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS A 22 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS A 23 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS A 24 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS A 25 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS A 26 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS A 27 UNP Q02750 EXPRESSION TAG SEQADV 7B9L ALA A 28 UNP Q02750 EXPRESSION TAG SEQADV 7B9L ALA A 29 UNP Q02750 EXPRESSION TAG SEQADV 7B9L ALA A 30 UNP Q02750 EXPRESSION TAG SEQADV 7B9L GLU A 31 UNP Q02750 EXPRESSION TAG SEQADV 7B9L ASN A 32 UNP Q02750 EXPRESSION TAG SEQADV 7B9L LEU A 33 UNP Q02750 EXPRESSION TAG SEQADV 7B9L TYR A 34 UNP Q02750 EXPRESSION TAG SEQADV 7B9L PHE A 35 UNP Q02750 EXPRESSION TAG SEQADV 7B9L GLN A 36 UNP Q02750 EXPRESSION TAG SEQADV 7B9L GLY A 302 UNP Q02750 LINKER SEQADV 7B9L SER A 303 UNP Q02750 LINKER SEQADV 7B9L GLY A 304 UNP Q02750 LINKER SEQADV 7B9L SER A 305 UNP Q02750 LINKER SEQADV 7B9L GLY A 306 UNP Q02750 LINKER SEQADV 7B9L SER A 307 UNP Q02750 LINKER SEQADV 7B9L MET B 20 UNP Q02750 INITIATING METHIONINE SEQADV 7B9L ALA B 21 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS B 22 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS B 23 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS B 24 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS B 25 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS B 26 UNP Q02750 EXPRESSION TAG SEQADV 7B9L HIS B 27 UNP Q02750 EXPRESSION TAG SEQADV 7B9L ALA B 28 UNP Q02750 EXPRESSION TAG SEQADV 7B9L ALA B 29 UNP Q02750 EXPRESSION TAG SEQADV 7B9L ALA B 30 UNP Q02750 EXPRESSION TAG SEQADV 7B9L GLU B 31 UNP Q02750 EXPRESSION TAG SEQADV 7B9L ASN B 32 UNP Q02750 EXPRESSION TAG SEQADV 7B9L LEU B 33 UNP Q02750 EXPRESSION TAG SEQADV 7B9L TYR B 34 UNP Q02750 EXPRESSION TAG SEQADV 7B9L PHE B 35 UNP Q02750 EXPRESSION TAG SEQADV 7B9L GLN B 36 UNP Q02750 EXPRESSION TAG SEQADV 7B9L GLY B 264 UNP Q02750 LINKER SEQADV 7B9L SER B 265 UNP Q02750 LINKER SEQADV 7B9L GLY B 266 UNP Q02750 LINKER SEQADV 7B9L SER B 267 UNP Q02750 LINKER SEQADV 7B9L GLY B 306 UNP Q02750 LINKER SEQADV 7B9L SER B 307 UNP Q02750 LINKER SEQRES 1 A 326 MET ALA HIS HIS HIS HIS HIS HIS ALA ALA ALA GLU ASN SEQRES 2 A 326 LEU TYR PHE GLN LEU GLU GLU LEU GLU LEU ASP GLU GLN SEQRES 3 A 326 GLN ARG LYS ARG LEU GLU ALA PHE LEU THR GLN LYS GLN SEQRES 4 A 326 LYS VAL GLY GLU LEU LYS ASP ASP ASP PHE GLU LYS ILE SEQRES 5 A 326 SER GLU LEU GLY ALA GLY ASN GLY GLY VAL VAL PHE LYS SEQRES 6 A 326 VAL SER HIS LYS PRO SER GLY LEU VAL MET ALA ARG LYS SEQRES 7 A 326 LEU ILE HIS LEU GLU ILE LYS PRO ALA ILE ARG ASN GLN SEQRES 8 A 326 ILE ILE ARG GLU LEU GLN VAL LEU HIS GLU CYS ASN SER SEQRES 9 A 326 PRO TYR ILE VAL GLY PHE TYR GLY ALA PHE TYR SER ASP SEQRES 10 A 326 GLY GLU ILE SER ILE CYS MET GLU HIS MET ASP GLY GLY SEQRES 11 A 326 SER LEU ASP GLN VAL LEU LYS LYS ALA GLY ARG ILE PRO SEQRES 12 A 326 GLU GLN ILE LEU GLY LYS VAL SER ILE ALA VAL ILE LYS SEQRES 13 A 326 GLY LEU THR TYR LEU ARG GLU LYS HIS LYS ILE MET HIS SEQRES 14 A 326 ARG ASP VAL LYS PRO SER ASN ILE LEU VAL ASN SER ARG SEQRES 15 A 326 GLY GLU ILE LYS LEU CYS ASP PHE GLY VAL SER GLY GLN SEQRES 16 A 326 LEU ILE ASP SER MET ALA ASN SER PHE VAL GLY THR ARG SEQRES 17 A 326 SER TYR MET SER PRO GLU ARG LEU GLN GLY THR HIS TYR SEQRES 18 A 326 SER VAL GLN SER ASP ILE TRP SER MET GLY LEU SER LEU SEQRES 19 A 326 VAL GLU MET ALA VAL GLY ARG TYR PRO ILE GLY SER GLY SEQRES 20 A 326 SER GLY SER MET ALA ILE PHE GLU LEU LEU ASP TYR ILE SEQRES 21 A 326 VAL ASN GLU PRO PRO PRO LYS LEU PRO SER GLY VAL PHE SEQRES 22 A 326 SER LEU GLU PHE GLN ASP PHE VAL ASN LYS CYS LEU ILE SEQRES 23 A 326 LYS ASN PRO ALA GLU ARG ALA ASP LEU LYS GLN LEU MET SEQRES 24 A 326 VAL HIS ALA PHE ILE LYS ARG SER ASP ALA GLU GLU VAL SEQRES 25 A 326 ASP PHE ALA GLY TRP LEU CYS SER THR ILE GLY LEU ASN SEQRES 26 A 326 GLN SEQRES 1 B 326 MET ALA HIS HIS HIS HIS HIS HIS ALA ALA ALA GLU ASN SEQRES 2 B 326 LEU TYR PHE GLN LEU GLU GLU LEU GLU LEU ASP GLU GLN SEQRES 3 B 326 GLN ARG LYS ARG LEU GLU ALA PHE LEU THR GLN LYS GLN SEQRES 4 B 326 LYS VAL GLY GLU LEU LYS ASP ASP ASP PHE GLU LYS ILE SEQRES 5 B 326 SER GLU LEU GLY ALA GLY ASN GLY GLY VAL VAL PHE LYS SEQRES 6 B 326 VAL SER HIS LYS PRO SER GLY LEU VAL MET ALA ARG LYS SEQRES 7 B 326 LEU ILE HIS LEU GLU ILE LYS PRO ALA ILE ARG ASN GLN SEQRES 8 B 326 ILE ILE ARG GLU LEU GLN VAL LEU HIS GLU CYS ASN SER SEQRES 9 B 326 PRO TYR ILE VAL GLY PHE TYR GLY ALA PHE TYR SER ASP SEQRES 10 B 326 GLY GLU ILE SER ILE CYS MET GLU HIS MET ASP GLY GLY SEQRES 11 B 326 SER LEU ASP GLN VAL LEU LYS LYS ALA GLY ARG ILE PRO SEQRES 12 B 326 GLU GLN ILE LEU GLY LYS VAL SER ILE ALA VAL ILE LYS SEQRES 13 B 326 GLY LEU THR TYR LEU ARG GLU LYS HIS LYS ILE MET HIS SEQRES 14 B 326 ARG ASP VAL LYS PRO SER ASN ILE LEU VAL ASN SER ARG SEQRES 15 B 326 GLY GLU ILE LYS LEU CYS ASP PHE GLY VAL SER GLY GLN SEQRES 16 B 326 LEU ILE ASP SER MET ALA ASN SER PHE VAL GLY THR ARG SEQRES 17 B 326 SER TYR MET SER PRO GLU ARG LEU GLN GLY THR HIS TYR SEQRES 18 B 326 SER VAL GLN SER ASP ILE TRP SER MET GLY LEU SER LEU SEQRES 19 B 326 VAL GLU MET ALA VAL GLY ARG TYR PRO ILE GLY SER GLY SEQRES 20 B 326 SER GLY SER MET ALA ILE PHE GLU LEU LEU ASP TYR ILE SEQRES 21 B 326 VAL ASN GLU PRO PRO PRO LYS LEU PRO SER GLY VAL PHE SEQRES 22 B 326 SER LEU GLU PHE GLN ASP PHE VAL ASN LYS CYS LEU ILE SEQRES 23 B 326 LYS ASN PRO ALA GLU ARG ALA ASP LEU LYS GLN LEU MET SEQRES 24 B 326 VAL HIS ALA PHE ILE LYS ARG SER ASP ALA GLU GLU VAL SEQRES 25 B 326 ASP PHE ALA GLY TRP LEU CYS SER THR ILE GLY LEU ASN SEQRES 26 B 326 GLN HET ANP A 401 31 HET T4N A 402 19 HET GOL A 403 6 HET SO4 A 404 5 HET MG A 405 1 HET ANP B 401 31 HET T4N B 402 19 HET MG B 403 1 HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM T4N ~{N}-(4-METHOXYPHENYL)-2-[(2~{S})-3- HETNAM 2 T4N OXIDANYLIDENETHIOMORPHOLIN-2-YL]ETHANAMIDE HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM MG MAGNESIUM ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ANP 2(C10 H17 N6 O12 P3) FORMUL 4 T4N 2(C13 H16 N2 O3 S) FORMUL 5 GOL C3 H8 O3 FORMUL 6 SO4 O4 S 2- FORMUL 7 MG 2(MG 2+) FORMUL 11 HOH *442(H2 O) HELIX 1 AA1 ASP A 43 GLN A 58 1 16 HELIX 2 AA2 LYS A 64 ASP A 66 5 3 HELIX 3 AA3 LYS A 104 GLN A 116 1 13 HELIX 4 AA4 VAL A 117 CYS A 121 5 5 HELIX 5 AA5 SER A 150 GLY A 159 1 10 HELIX 6 AA6 PRO A 162 LYS A 185 1 24 HELIX 7 AA7 LYS A 192 SER A 194 5 3 HELIX 8 AA8 SER A 212 MET A 219 1 8 HELIX 9 AA9 SER A 231 GLY A 237 1 7 HELIX 10 AB1 SER A 241 GLY A 259 1 19 HELIX 11 AB2 ALA A 309 GLU A 320 1 12 HELIX 12 AB3 SER A 331 LEU A 342 1 12 HELIX 13 AB4 ASP A 351 VAL A 357 1 7 HELIX 14 AB5 HIS A 358 GLU A 367 1 10 HELIX 15 AB6 ASP A 370 GLY A 380 1 11 HELIX 16 AB7 ASP B 43 GLN B 58 1 16 HELIX 17 AB8 LYS B 64 ASP B 66 5 3 HELIX 18 AB9 LYS B 104 GLN B 116 1 13 HELIX 19 AC1 VAL B 117 CYS B 121 5 5 HELIX 20 AC2 SER B 150 GLY B 159 1 10 HELIX 21 AC3 PRO B 162 LYS B 185 1 24 HELIX 22 AC4 LYS B 192 SER B 194 5 3 HELIX 23 AC5 SER B 212 ALA B 220 1 9 HELIX 24 AC6 SER B 231 GLN B 236 1 6 HELIX 25 AC7 SER B 241 GLY B 259 1 19 HELIX 26 AC8 ALA B 309 GLU B 320 1 12 HELIX 27 AC9 SER B 331 LEU B 342 1 12 HELIX 28 AD1 ASP B 351 VAL B 357 1 7 HELIX 29 AD2 HIS B 358 GLU B 367 1 10 HELIX 30 AD3 ASP B 370 GLY B 380 1 11 SHEET 1 AA1 5 PHE A 68 ALA A 76 0 SHEET 2 AA1 5 GLY A 80 HIS A 87 -1 O LYS A 84 N SER A 72 SHEET 3 AA1 5 LEU A 92 HIS A 100 -1 O ARG A 96 N PHE A 83 SHEET 4 AA1 5 GLU A 138 GLU A 144 -1 O MET A 143 N ALA A 95 SHEET 5 AA1 5 PHE A 129 SER A 135 -1 N PHE A 133 O SER A 140 SHEET 1 AA2 2 ILE A 196 VAL A 198 0 SHEET 2 AA2 2 ILE A 204 LEU A 206 -1 O LYS A 205 N LEU A 197 SHEET 1 AA3 5 PHE B 68 ALA B 76 0 SHEET 2 AA3 5 GLY B 80 HIS B 87 -1 O VAL B 82 N GLY B 75 SHEET 3 AA3 5 VAL B 93 HIS B 100 -1 O LEU B 98 N VAL B 81 SHEET 4 AA3 5 GLU B 138 GLU B 144 -1 O MET B 143 N ALA B 95 SHEET 5 AA3 5 PHE B 129 SER B 135 -1 N PHE B 133 O SER B 140 SHEET 1 AA4 2 ILE B 196 VAL B 198 0 SHEET 2 AA4 2 ILE B 204 LEU B 206 -1 O LYS B 205 N LEU B 197 LINK OD1 ASN A 195 MG MG A 405 1555 1555 2.12 LINK OD2 ASP A 208 MG MG A 405 1555 1555 1.98 LINK O2G ANP A 401 MG MG A 405 1555 1555 1.98 LINK O2B ANP A 401 MG MG A 405 1555 1555 2.04 LINK O1A ANP A 401 MG MG A 405 1555 1555 2.12 LINK MG MG A 405 O HOH A 582 1555 1555 2.09 LINK OD1 ASN B 195 MG MG B 403 1555 1555 2.05 LINK OD2 ASP B 208 MG MG B 403 1555 1555 2.13 LINK O2G ANP B 401 MG MG B 403 1555 1555 1.95 LINK O2B ANP B 401 MG MG B 403 1555 1555 1.99 LINK O1A ANP B 401 MG MG B 403 1555 1555 2.11 LINK MG MG B 403 O HOH B 537 1555 1555 2.18 CRYST1 57.950 72.080 158.160 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017256 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013873 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006323 0.00000